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Summary: A total of 224 diabetics and 221 non-diabetics (control) were involved in this study, to 
determine the relative incidence of diabetes mellitus in ABO/Rhesus blood group.  The current criteria 
for the diagnosis f diabetes mellitus were applied in differentiating the diabetics from the non-diabetics.  
Blood group, fasting blood sugar (FBS) and random blood sugar (RBG) were determined using 
standard methods.  Type I, Type II and gestational diabetes mellitus were identified in this study.  
Biodata information were obtained during history taking and from subject hospital case note.  The 
mean age of diabetics was 50.9 + 11.4 (SD) with age range of 24-72 years.  Mean age for control was 
49.21 + 9.25 with age range of 24-70 years.  There were no significant differences between the mean 
ages of the two groups.  Blood group O
-
 and A
+
 were significantly (P<0.01)  higher among the 
diabetics than non diabetics. Blood group O
+
 was significantly (P<0.01)  lower in diabetics than in the 
control population.  Blood group O
-
 and A
+
 therefore appears to be more susceptible to diabetes 
mellitus. 
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Introduction    
It was long suggested that the ABO blood 
group system had evolved under a positive 
selection pressure in both humans and other 
primates (O’huigen et al., 1997).  This implies 
that certain ABO groups provide a selected 
vulnerability to individuals possessing a 
particular ABO blood group.  Researchers have 
made considerable attempts to determine the 
significance of particular ABO phenotypes to 
disease susceptibility.  The relationship between 
ABO blood groups and disease susceptibility 
has generated a lot of interest.  Individuals with 
blood group O have been found to be at a 
higher risk of contracting cholera than those 
with other blood groups. The ratio of this risk 
of group O to group A individuals has been 
reported as 1.35:1 (Issitt, and Anstee, 1999).  
Oral candidiasis shows a higher incidence of 
group O over other ABO groups (Burford-
Mason, 1988; Thom, 1989). 
Small pox virus has been found to carry 
an A antigen-like structure, so that individuals 
who possess a naturally occurring anti-A (group 
O and B individuals) are thought to have an 
increased resistance to the infection (Vogel et 
al., 1960; Adalsteinson, 1985; Issitt and Anstee,  
1999).  Some ABO blood groups are also 
believed to have a higher incidence in certain 
malignancies; many tumors have been 
demonstrated in large trials to have a 
significantly higher incidence in group A 
individuals (Issitt and Anstee, 1999).  This 
could be attributed to the inability of the 
immune system of group A individuals to 
recognize the A like antigen of the tumour cells 
as foreign and cannot destroy them, but group 
O and B individuals do have a naturally 
occurring anti- A that are most likely to destroy 
tumour cells (Issitt and Anstee,  1999). 
An individual ABO blood group can also 
be a risk factor in coagulation defect.  It has 
been reported that group O individuals are 
proportionately more prone to bleeding than 
individuals of the other blood groups; and 
group A individuals with highest incidence of 
thrombosis than in any other group (Issitt and 
Anstee,  1999). 
This study was designed to determine the 
relative incidence of diabetes mellitus in the 
different ABO/Rhesus blood groups in South-
Eastern Nigeria. 
 
Materials and Methods 
Two major and two make up centres were 
chosen for this study.  The University of 
Calabar Teaching Hospital and the University 
of Uyo Teaching Hospital were the major 
centres.  The make up centers included Heritage 
Specialists Clinic, Calabar and St. Luke’s 
1 
Hospital, Anua, Akwa Ibom State all in South 
Eastern Nigeria 
A total of 445 subjects took part in this 
study with 244 making up the test group 
(diabetics) and 221 (non-diabetics) as control.  
There was no application of inclusion/exclusion 
criteria as basically all those attending routine 
diabetic clinics in the various centers were 
cooperative and eager to participate in the 
study.  However, some subjects failed to offer 
some information they considered too personal. 
Application for permission to carry out 
the study was forwarded to the ethics and rules 
committee of the respective centers.  The extent 
and purpose of the study were clearly explained 
and informed consent obtained from subjects.  
The rules on respect of person were duly 
observed.  Subjects were interviewed and 
samples collected during their weekly diabetic 
clinic visit and the research questionnaire filled 
accordingly. The control groups were randomly 
selected from those on routine medical/surgical 
check-ups, confirmed to be non-diabetic. 
The blood samples were collected by 
venepuncture with 2 ml emptied into EDTA 
bottles and about 2 ml fixed in fluoride bottles.  
Blood sample in the EDTA bottle was used for 
blood grouping while that in the fluoride bottle 
was used for random and fasting blood sugar 
estimation as was applicable.  Blood grouping 
was done according to method described by 
Dacie and Lewis (1991). 
Blood sugar estimation was carried out 
with glucometer.  Sugar strip was inserted into 
a one stop glucometer, and a drop of blood was 
also placed on the sample spot.  The meter 
automatically issued result in mg/dl after 45 
seconds.  This was converted to mmol/l by 
dividing by 18. 
The data were entered in Microsoft excel 
for analysis.  Further analysis was carried out 
using instant graph-pad 2.5a.  The chi-square 
and students t-test were employed to compare 
two sets of data.  Analysis of variance was 
employed where comparison of three or more 
variables was involved. P<0.05 was considered 
statistically significant. 
 
Results 
 The results as presented in table 1 show 
the blood groups (ABO and Rhesus systems) 
that were seen among the diabetics.  When 
compared with control (non-diabetic) groups, 
those with O
- 
and A
+
 were significantly higher 
among the diabetics than the non-diabetics.  
The values were 6.25%, 33.03% for diabetics 
with O
- 
and A
+
 respectively, and 0.90% and 
28.95% for non-diabetics with O
+
 blood group 
(46.42%) were significantly lower than the 
control population with O
+
 and A
-
 respectively.  
However, diabetics with O
+
 blood group 
(52.91%), (P<0.01). 
Blood groups B and AB did not show any 
significant difference between the test and 
control groups, as illustrated in Figure 1. 
 
Table 1: ABO/Rhesus blood groups distribution 
among diabetics and non-diabetics 
 
Blood 
Group 
Diabetics 
(N=224) 
Non-Diabetics 
(N=221) 
O
-
 14(6.25%) 2(0.90%)** 
O
+
 104(46.42%) 117(52.91%)** 
A
+ 
74(33.03%) 64(28.95%)** 
AB
+ 
12(5.35%) 17(7.69%)
NS 
B
+ 
26(11.60%) 31(14.02%)
NS 
 
 
** = P<0.01; NS = NS = Not Significant  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Blood sugar determination was done.  The 
mean values of the concentration of fasting 
blood sugar (FBS), and random blood sugar 
(RBS) as was applicable for diabetics and 
control groups are shown in Table 2. The 
diabetics had significantly higher fasting and 
random blood sugar concentration than  the 
non-diabetics, (P<0.01). This illustrated in 
Figure 2. 
 
Table 2: Fasting and random blood sugar 
levels in diabetics and non-diabetics.  
 
Blood Sugar 
Concentration 
(mmol/l)  
Diabetics 
Mean ± SD 
Non-
Diabetics 
Mean ± SD 
FBS
 
7.3±0.68  4.2±0.41** 
RBS
 
18.96±0.89 10.1±0.72**
 
 
** = P<0.01; FBS = Fasting Blood Sugar;  
RBS = Random Blood Sugar. 
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Figure 1: Blood Group (ABO/Rhesus) among  
Diabeticsand Non-diabetics  population.   
*** = P<0.01.
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Figure2: Blood sugar concentration among 
diabetic and non-diabetic population. Values 
are mean + SEM. 
 
Discussion 
Diabetes mellitus was observed to occur in 
all the ABO/Rhesus blood groups.  Both the 
Rhesus positive and negative were affected in 
group O.  From the results presented above, 
blood group O
+
 had the highest prevalence 
among the diabetics (46.42%), although, 
comparatively this was significantly lower than 
the control group.  On the other hand, there was 
significantly higher incidence of diabetes 
mellitus in blood group O
- 
(6.25% and A
+
 
(33%) subjects when compared to their 
distribution in the control group (0.9%) and 
28.95% for O
-
 and A
+
 respectively.  Blood 
groups O
-
 and A
+
had been previously reported 
to enjoy a higher incidence of other disease 
conditions namely; cholera, oral candidiasis, 
malignancies, coagulation defect and 
thrombosis (Daniels, 1995; Issitt, and Anstee, 
1999).  Are blood groups O
-
 and A
+ 
endangered 
“specie”?  This is a subject for further research 
work. 
Several diabetics had a fairly good control 
of their blood sugar level, though the majority 
of them tilted to the above normal range. It has 
been noted that the risk of chronic 
complications increases as a function of the 
duration of hyperglycemia, while acute 
complications are directly related to the level of 
hyperglycemia (Ohkubo et al., 1995).  The 
fairly good control of the blood sugar of 
subjects, possibly explain the low incidence of 
acute and chronic complications reported in this 
study. 
 
 
 
 
 
 
In conclusion, it is likely that O
-
 and A
+
 
individuals are more susceptible to diabetes 
mellitus. 
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